Industrifonden leads €11m round in Nuevolution

Industrifonden joined previous backers Sunstone Capital, SEB Venture Capital and SEB Utvecklingsstiftelse. SEB first invested in the company in 2003.

Company
Nuevolution A/S is a biotechnology company based in Copenhagen, Denmark. It operates a trademarked platform, Chemetics, which is a small molecule compound library used for screening pharmaceuticals' compounds. Its current library collection exceeds one billion small molecule compounds.

Founded in 2001, Nuevolution has commercial agreements with Merck & Co, Lexicon Pharmceuticals, GlaxoSmithKline, Novartis Pharma and Boehringer Ingelheim.

People
Jones Brambeck, investment manager, led the deal on behalf of Industrifonden. Alex Gouliaev is CEO of Nuevolution.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• Nordics
• Now researching
• Healthcare
• SEB Venture Capital
• Sunstone Capital A/S
• Industrifonden